{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Entrada Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"TRDA"},"Address":{"label":"Address","value":"6 TIDE STREET, BOSTON, Massachusetts, 02210, United States"},"Phone":{"label":"Phone","value":"+1 857 520-9158"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.entradatx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dipal Doshi","title":"Chief Executive Officer & Director"},{"name":"Natarajan Sethuraman","title":"President-Research & Development"},{"name":"Nathan J. Dowden","title":"President & Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}